OptiBiotix Health, which develops compounds to tackle obesity, high cholesterol and diabetes, has won a US order for its SlimBiome\u00ae product.<\/p>\n
The order from a leading American weight loss brand will see SlimBiome\u00ae, which reduces hunger, be incorporated into a range of flavoured drinks.<\/p>\n
York-based OptiBiotix has been working with this brand for more than 18 months to carry out human studies which allows the brand to make health claims of hunger control on its products in the USA.<\/p>\n
OptiBiotix expect further orders for a second product, a tablet containing SlimBiome\u00ae, within H1 2025.<\/p>\n
Stephen O’Hara, CEO of OptiBiotix, said: “We are pleased to announce the first order for the use of SlimBiome\u00ae in one of the USA’s leading weight management brands. The use of SlimBiome\u00ae has allowed the brand to make health claims of hunger control on its products which differentiate them from other products on the market. We anticipate more orders and product launches with this brand as it extends the range of products containing SlimBiome\u00ae in the USA market in 2025.<\/p>\n
\u201cFollowing the launch of the anti-obesity drugs, natural non-drug alternatives to reduce hunger and cravings are actively being sought by consumers. This announcement demonstrates that the science and multiple human studies carried out on SlimBiome\u00ae is now attracting the interest of major brands around the world.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"
OptiBiotix Health, which develops compounds to tackle obesity, high cholesterol and diabetes, has won a US order for its SlimBiome\u00ae product<\/p>\n","protected":false},"author":271992,"featured_media":2058146,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"coauthors":[137100],"class_list":["post-2137631","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-featured-story","tag-yorkshire"],"yoast_head":"\n